Suchergebnisse - "Dorward, Jienchi"

PubPharm (14)

1

Ivermectin for COVID-19 in adults in the community (PRINCIPLE) : An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

enthalten in: The Journal of infection | 2024

von Hayward, G. | Yu, L. | Little, P. | +23

2

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

enthalten in: Nature communications | 2024

von Standing, J. | Buggiotti, L. | Guerra-Assuncao, J. | +51

3

Point-of-Care Viral Load Testing to Manage HIV Viremia During the Rollout of Dolutegravir-Based ART in South Africa : A Randomized Feasibility Study (POwER)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Dorward, J. | Sookrajh, Y. | Lessells, R. | +13

4

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC) : an open-label, platform-adaptive randomised controlled trial

enthalten in: Lancet (London, England) | 2023

von Butler, C. | Hobbs, F. | Gbinigie, O. | +133

CommentIn: Lancet. 2023 Jan 28;401(10373):250-251. - PMID 36566762

5

Inhaled Budesonide for COVID-19 in People at Higher Risk of Complications in the Community : The UK National Community Randomi

enthalten in: Annals of family medicine | 2023

von Hobbs, R. | Gbinigie, O. | Ogburn, E. | +5

6

Colchicine for COVID-19 in the community (PRINCIPLE) : a randomised, controlled, adaptive platform trial

enthalten in: The British journal of general practice : the journal of the Royal College of General Practitioners | 2022

von Dorward, J. | Yu, L. | Hayward, G. | +19

7

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE) : a randomised, controlled, open-label, adaptive platform trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Butler, C. | Yu, L. | Dorward, J. | +19

CommentIn: Lancet Respir Med. 2021 Sep;9(9):943-945. - PMID 34331866

8

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE) : a randomised, controlled, open-label, adaptive platform trial

enthalten in: Lancet (London, England) | 2021

von Yu, L. | Bafadhel, M. | Dorward, J. | +50

CommentIn: Lancet. 2021 Sep 4;398(10303):818-819. - PMID 34388397

9

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE) : a randomised, controlled, open-label, adaptive platform trial

enthalten in: Lancet (London, England) | 2021

von PRINCIPLE Trial Collaborative Group | Butler, C. | Dorward, J. | +16

CommentIn: Lancet. 2021 Mar 20;397(10279):1036-1037. - PMID 33743853

10

Acceptability of point-of-care viral load testing to facilitate differentiated care : a qualitative assessment of people living with HIV and nurses in South Africa

enthalten in: BMC health services research | 2020

von Msimango, L. | Gibbs, A. | Shozi, H. | +5